Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
FDA approves Satsuma's migraine nasal spray after rejection in 2024
2 months ago
FDA+
Biogen says Leqembi sales are improving slowly following lackluster launch
2 months ago
Lilly meets sales expectations, but Novo gains on PBM win
2 months ago
Amicus grabs Dimerix’s rare kidney disease drug for $30M upfront
2 months ago
Deals
Moderna expands effort to rein in costs in an ‘uncertain environment’
2 months ago
R&D
BeiGene scores a win from US Patent Office in spat over Brukinsa
2 months ago
Law
Regeneron loses bid to fend off DOJ fight over Eylea Medicare payments
2 months ago
Law
FDA approves J&J's rare disease drug that's expected to compete with argenx and UCB
2 months ago
FDA+
Updated: Novartis to buy Regulus Therapeutics for up to $1.7B
2 months ago
Deals
GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says
2 months ago
Manufacturing
BridgeBio’s Attruby outperforms sales expectations, shares rise
2 months ago
Pfizer CEO Bourla suggests pharma tariffs will focus on US adversaries, not allies
2 months ago
China
Join us at 12 p.m. ET: How pharma is reacting to ‘Liberation Day’
2 months ago
Editor's note
FDA approves Abeona’s skin disease cell therapy
2 months ago
Cell/Gene Tx
FDA+
With a new CEO, oligonucleotide biotech Creyon forges Eli Lilly partnership
2 months ago
Financing
Startups
Hims and Novo Nordisk partner to offer discounted Wegovy
2 months ago
Health Tech
AstraZeneca, Novartis execute ‘US for US’ strategy as pharma tariffs near
2 months ago
China
Manufacturing
Pfizer launches a new wave of cost cuts, expects $7.7B in total savings through 2027
2 months ago
AstraZeneca posts another Truqap study fail, says China import tax could triple
2 months ago
China
Law
Novartis continues earnings winning streak as it raises 2025 sales expectations
2 months ago
R&D
Vaxart says it can resume next-gen Covid work, will screen participants for oral vaccine trial
2 months ago
FDA+
Coronavirus
Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny
2 months ago
FDA+
Coronavirus
WuXi AppTec sees growth after 2024 dip, plans ‘lean’ operations to temper ‘external opportunities’
2 months ago
China
Manufacturing
Daiichi Sankyo says production boost in US will help cushion tariff impact
2 months ago
Manufacturing
First page
Previous page
7
8
9
10
11
12
13
Next page
Last page
